The B55α Regulatory Subunit of Protein Phosphatase 2A Mediates Fibroblast Growth Factor-Induced p107 Dephosphorylation and Growth Arrest in Chondrocytes Articles of Significant Interest Selected from This Issue by the Editors

Molecular and Cellular Biology

Volumn 33, Issue 15, 2013, Pages 2865-2878

  Kolupaeva, Victoria ^a   Daempfling, Lea ^a   Basilico, Claudio ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; DIMER; FIBROBLAST GROWTH FACTOR; HOLOENZYME; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE 2A B55ALPHA; PROTEIN P107; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARTILAGE CELL; CELL CYCLE ARREST; CELL GROWTH; CHONDROSARCOMA; CONTROLLED STUDY; GENE MUTATION; GROWTH DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHONDROCYTES; CHONDROSARCOMA; FIBROBLAST GROWTH FACTOR 1; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN INTERACTION MAPS; PROTEIN PHOSPHATASE 2; PROTEIN SUBUNITS; RATS; RETINOBLASTOMA-LIKE PROTEIN P107;

EID: 84880673885     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01730-12     Document Type: Article

References (51)

1. Aviezer D, Golembo M, Yayon A. 2003. Fibroblast growth factor receptor-3 as a therapeutic target for achondroplasia- genetic short limbed dwarfism. Curr. Drug Targets 4:353-365.
2. Laplantine E, Rossi F, Sahni M, Basilico C, Cobrinik D. 2002. FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest. J. Cell Biol. 158:741-750.
3. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10:1633-1644.
4. Dyson N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245-2262.
5. Dailey L, Laplantine E, Priore R, Basilico C. 2003. A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J. Cell Biol. 161:1053-1066.
6. Aikawa T, Segre GV, Lee K. 2001. Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2. J. Biol. Chem. 276:29347-29352.
7. Janssens V, Longin S, Goris J. 2008. PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends Biochem. Sci. 33:113-121.
8. Janssens V, Rebollo A. 2012. The role and therapeutic potential of Ser/Thr phosphatase PP2A in apoptotic signalling networks in human cancer cells. Curr. Mol. Med. 12:268-287.
9. Kalev P, Sablina AA. 2011. Protein phosphatase 2A as a potential target for anticancer therapy. Anticancer Agents Med. Chem. 11:38-46.
10. Kalev P, Simicek M, Vazquez I, Munck S, Chen L, Soin T, Danda N, Chen W, Sablina A. 2012. Loss of PPP2R2A inhibits homologous recombination DNA repair and predicts tumor sensitivity to PARP inhibition. Cancer Res. 72:6414-6424.
11. Westermarck J, Hahn WC. 2008. Multiple pathways regulated by the tumor suppressor PP2A in transformation. Trends Mol. Med. 14:152-160.
12. Junttila MR, Puustinen P, Niemela M, Ahola R, Arnold H, Bottzauw T, Ala-aho R, Nielsen C, Ivaska J, Taya Y, Lu SL, Lin S, Chan EK, Wang XJ, Grenman R, Kast J, Kallunki T, Sears R, Kahari VM, Westermarck J. 2007. CIP2A inhibits PP2A in human malignancies. Cell 130:51-62.
13. Sablina AA, Hahn WC. 2008. SV40 small T antigen and PP2A phosphatase in cell transformation. Cancer Metastasis Rev. 27:137-146.
14. Gharbi-Ayachi A, Labbe JC, Burgess A, Vigneron S, Strub JM, Brioudes E, Van-Dorsselaer A, Castro A, Lorca T. 2010. The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A. Science 330:1673-1677.
15. Schmitz MH, Held M, Janssens V, Hutchins JR, Hudecz O, Ivanova E, Goris J, Trinkle-Mulcahy L, Lamond AI, Poser I, Hyman AA, Mechtler K, Peters JM, Gerlich DW. 2010. Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat. Cell Biol. 12:886-893.
16. Wurzenberger C, Gerlich DW. 2011. Phosphatases: providing safe passage through mitotic exit. Nat. Rev. Mol. Cell Biol. 12:469-482.
17. Kuo YC, Huang KY, Yang CH, Yang YS, Lee WY, Chiang CW. 2008. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J. Biol. Chem. 283:1882-1892.
18. Voronkov M, Braithwaite SP, Stock JB. 2011. Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease. Future Med. Chem. 3:821-833.
19. Yan L, Guo S, Brault M, Harmon J, Robertson RP, Hamid R, Stein R, Yang E. 2012. The B55alpha-containing PP2A holoenzyme dephosphorylates FOXO1 in islet beta-cells under oxidative stress. Biochem. J. 444:239-247.
20. Reid MA, Wang WI, Rosales KR, Welliver MX, Pan M, Kong M. 2013. The B55alpha subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation. Mol. Cell 50:200-211.
21. Zhang W, Yang J, Liu Y, Chen X, Yu T, Jia J, Liu C. 2009. PR55 alpha, a regulatory subunit of PP2A, specifically regulates PP2A-mediated betacatenin dephosphorylation. J. Biol. Chem. 284:22649-22656.
22. Jayadeva G, Kurimchak A, Garriga J, Sotillo E, Davis AJ, Haines DS, Mumby M, Grana X. 2010. B55alpha PP2A holoenzymes modulate the phosphorylation status of the retinoblastoma-related protein p107 and its activation. J. Biol. Chem. 285:29863-29873.
23. Voorhoeve PM, Hijmans EM, Bernards R. 1999. Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein. Oncogene 18:515-524.
24. Raucci A, Laplantine E, Mansukhani A, Basilico C. 2004. Activation of the ERK1/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes. J. Biol. Chem. 279:1747-1756.
25. Thirion S, Berenbaum F. 2004. Culture and phenotyping of chondrocytes in primary culture. Methods Mol. Med. 100:1-14.
26. Longin S, Zwaenepoel K, Louis JV, Dilworth S, Goris J, Janssens V. 2007. Selection of protein phosphatase 2A regulatory subunits is mediated by the C terminus of the catalytic subunit. J. Biol. Chem. 282:26971-26980.
27. Kolupaeva V, Laplantine E, Basilico C. 2008. PP2A-mediated dephosphorylation of p107 plays a critical role in chondrocyte cell cycle arrest by FGF. PLoS One 3:e3447. doi:10.1371/journal.pone.0003447.
28. Browne GJ, Proud CG. 2002. Regulation of peptide-chain elongation in mammalian cells. Eur. J. Biochem. 269:5360-5368.
29. Kaul G, Pattan G, Rafeequi T. 2011. Eukaryotic elongation factor-2 (eEF2): its regulation and peptide chain elongation. Cell Biochem. Funct. 29:227-234.
30. Lin KW, Yakymovych I, Jia M, Yakymovych M, Souchelnytskyi S. 2010. Phosphorylation of eEF1A1 at Ser300 by TbetaR-I results in inhibition of mRNA translation. Curr. Biol. 20:1615-1625.
31. Ryazanov AG. 2002. Elongation factor-2 kinase and its newly discovered relatives. FEBS Lett. 514:26-29.
32. Tsuchiya Y, Denison FC, Heath RB, Carling D, Saggerson D. 2012. 5=-AMP-activated protein kinase is inactivated by adrenergic signalling in adult cardiac myocytes. Biosci. Rep. 32:197-213.
33. Papakonstanti EA, Stournaras C. 2002. Association of PI-3 kinase with PAK1 leads to actin phosphorylation and cytoskeletal reorganization. Mol. Biol. Cell 13:2946-2962.
34. Rozenblatt-Rosen O, Mosonego-Ornan E, Sadot E, Madar-Shapiro L, Sheinin Y, Ginsberg D, Yayon A. 2002. Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations. J. Cell Sci. 115: 553-562.
35. Kolupaeva V, Janssens V. 2013. PP1 and PP2A phosphatases-cooperating partners in modulating retinoblastoma protein activation. FEBS J. 280:627-643.
36. Woo MS, Sanchez I, Dynlacht BD. 1997. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Mol. Cell. Biol. 17:3566-3579.
37. Shi Y. 2009. Serine/threonine phosphatases: mechanism through structure. Cell 139:468-484.
38. Slupe AM, Merrill RA, Strack S. 2011. Determinants for substrate specificity of protein phosphatase 2A. Enzyme Res. 2011:398751. doi:10.4061/2011/398751.
39. Xu C, Min J. 2011. Structure and function of WD40 domain proteins. Protein Cell 2:202-214.
40. Xu Y, Chen Y, Zhang P, Jeffrey PD, Shi Y. 2008. Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. Mol. Cell 31:873-885.
41. Blom N, Gammeltoft S, Brunak S. 1999. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294: 1351-1362.
42. Fukunaga K, Muller D, Ohmitsu M, Bako E, DePaoli-Roach AA, Miyamoto E. 2000. Decreased protein phosphatase 2A activity in hippocampal long-term potentiation. J. Neurochem. 74:807-817.
43. Mansukhani A, Bellosta P, Sahni M, Basilico C. 2000. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J. Cell Biol. 149:1297-1308.
44. Denker AE, Haas AR, Nicoll SB, Tuan RS. 1999. Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells. I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures. Differentiation 64:67-76.
45. Miller JP, Yeh N, Hofstetter CP, Keskin D, Goldstein AS, KoffA. 2012. p27kip1 protein levels reflect a nexus of oncogenic signaling during cell transformation. J. Biol. Chem. 287:19775-19785.
46. Sontag JM, Nunbhakdi-Craig V, White CL, III, Halpain S, Sontag E. 2012. The protein phosphatase PP2A/Balpha binds to the microtubuleassociated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: implications for tauopathies. J. Biol. Chem. 287:14984-14993.
47. Hirschi A, Cecchini M, Steinhardt RC, Schamber MR, Dick FA, Rubin SM. 2010. An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein. Nat. Struct. Mol. Biol. 17:1051-1057.
48. Castano E, Kleyner Y, Dynlacht BD. 1998. Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor. Mol. Cell. Biol. 18:5380-5391.
49. Garriga J, Jayaraman AL, Limon A, Jayadeva G, Sotillo E, Truongcao M, Patsialou A, Wadzinski BE, Grana X. 2004. A dynamic equilibrium between CDKs and PP2A modulates phosphorylation of pRB, p107 and p130. Cell Cycle 3:1320-1330.
50. Alvarez-Fernandez M, Halim VA, Aprelia M, Laoukili J, Mohammed S, Medema RH. 2011. Protein phosphatase 2A (B55alpha) prevents premature activation of forkhead transcription factor FoxM1 by antagonizing cyclin A/cyclin-dependent kinase-mediated phosphorylation. J. Biol. Chem. 286:33029-33036.
51. Junttila MR, Saarinen S, Schmidt T, Kast J, Westermarck J. 2005. Single-step Strep-tag purification for the isolation and identification of protein complexes from mammalian cells. Proteomics 5:1199-1203.